WallStreetZenWallStreetZen

NASDAQ: OCUL
Ocular Therapeutix Inc Stock Ownership - Who owns Ocular Therapeutix?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ocular Therapeutix Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nadia WaheedChief Medical Officer2026-06-0314,828$8.27
$122.63kSell
Peter KaiserChief Development Officer2026-05-262,967$8.20
$24.33kSell
Pravin DugelExecutive Chairman President and CEO2026-05-2621,156$8.20
$173.48kSell
Jeffrey S. HeierChief Scientific Officer2026-05-263,018$8.20
$24.75kSell
Sanjay NayakChief Strategy Officer2026-05-261,858$8.20
$15.24kSell
Peter KaiserChief Development Officer2026-02-232,810$8.28
$23.27kSell
Pravin DugelExecutive Chairman President and CEO2026-02-2320,056$8.28
$166.06kSell
Sanjay NayakChief Strategy Officer2026-02-231,759$8.28
$14.56kSell
Jeffrey S. HeierChief Scientific Officer2026-02-233,057$8.28
$25.31kSell
Richard L. Md LindstromDirector2026-02-2060,229$7.66
$461.35kBuy

1 of 3

OCUL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OCUL insiders and whales buy or sell their stock.

OCUL Shareholders

What type of owners hold Ocular Therapeutix Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.91%32,653,764$291.92MInstitution
Deep Track Capital LP8.99%19,686,282$176.00MInstitution
Blackrock Inc7.37%16,132,931$144.23MInstitution
Avoro Capital Advisors LLC5.62%12,315,000$110.10MInstitution
Summer Road LLC5.43%11,879,825$106.21MInstitution
Venrock Adviser LLC4.73%10,346,926$92.50MInstitution
Opaleye Management Inc4.66%10,213,500$91.31MInsider
Vanguard Capital Management LLC3.98%8,719,039$77.95MInstitution
Summer Road LLC3.92%8,591,401$76.81MInsider
Price T Rowe Associates Inc2.69%5,897,149$52.72MInstitution

1 of 3

OCUL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OCUL84.70%15.30%Net SellingNet Selling
IMNM93.68%6.32%Net SellingNet Selling
NTLA73.66%26.34%Net Buying
AUPH57.47%14.58%Net BuyingNet Buying
MLYS70.05%29.95%Net BuyingNet Buying
View Top Biotech Stocks

Ocular Therapeutix Stock Ownership FAQ

Who owns Ocular Therapeutix?

Ocular Therapeutix (NASDAQ: OCUL) is owned by 94.42% institutional shareholders, 17.05% Ocular Therapeutix insiders, and 0.00% retail investors. Opaleye Management Inc is the largest individual Ocular Therapeutix shareholder, owning 10.21M shares representing 4.66% of the company. Opaleye Management Inc's Ocular Therapeutix shares are currently valued at $98.46M.

If you're new to stock investing, here's how to buy Ocular Therapeutix stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.